Brad Maron begins term as PVRI President 2026–28
Watch Brad’s first interview as PVRI President above.
PVRI is delighted to welcome Brad Maron as President for 2026–28. A long-standing member of PVRI, Brad begins his two-year term with a clear focus on strengthening community, expanding opportunity, and ensuring that advances in PH research translate into meaningful impact for patients worldwide.
In his first interview as President, Brad reflected on what motivated him to take on the role.
“I was very interested in the possibility of serving in a leadership role at PVRI because this is an important organisation that focuses really on the concept of community — among scientists, researchers, clinicians, and most importantly, the patients living worldwide with different forms of pulmonary vascular disease.”
He continued:
“PVRI has been exceptional in its primary goal of bringing people together across all of those different interests for bettering our understanding and our ability to treat patients who are affected by this important and oftentimes complicated disease.”
Expanding involvement across the PH community
Looking ahead to his term, Brad emphasised expanding engagement across both research and clinical practice.
“The goals will be to expand involvement and opportunities for everyone who has an interest in pulmonary hypertension across the research and clinical space to be part of our mission.”
A key step will be broadening leadership opportunities.
“We will be expanding leadership opportunities by forming a cabinet that increases the number of roles that people can identify with and become affiliated with.”
He explained that this approach will deepen PVRI’s ability to address important unmet needs across a wide range of priority topics.
At the same time, he reinforced PVRI’s commitment to advancing science through a global health lens.
“Advances that we support must ultimately be brought back to the patients who are affected by the disease, regardless of where they live.”
Addressing global challenges in PH care
Brad identified access to care as one of the most pressing challenges facing the global PH community.
“Most patients are diagnosed or cared for in a very select number of locations across the world. Yet the vast majority of people living with pulmonary hypertension… are in areas outside of those destination centres.”
While economic and geopolitical barriers exist, he stressed the importance of collaboration and partnership.
“Identifying creative solutions and building partnerships with key people who are empowered to help form collaborations that can knock down those barriers is probably one of our greatest assets.”
He added that PVRI “has always been and will continue to be at the very core of that mission.”
Breaking silos and strengthening collaboration
Brad also highlighted the need for stronger multidisciplinary collaboration. As medicine has become increasingly specialised, fragmentation can limit progress in complex diseases such as PH.
“Opportunities to improve clinical trial design, enrolment, and the implementation of different treatments can only be strengthened by collaborating with investigators who operate in adjacent spaces.”
Drawing on his own experience working closely with pulmonologists, radiologists, and other specialists, he sees “great opportunity to improve our efficiency and overall success” through these kinds of partnerships.
Supporting early career members and global representation
Equity, inclusion, and opportunity will remain central themes throughout his presidency.
“Our greatest strength as an organisation is — and will always be — the young investigators and our members that represent areas of the world that are less well represented in academic medicine and scientific ventures.”
Brad emphasised that this requires “solid, steadfast commitment to prioritisation and to protecting their advancement and their participation.”
Members, he said, should expect to see continued resource allocation to ease participation for colleagues from low- and middle-income countries, alongside programming that reflects diverse perspectives.
“We have a confirmed and steadfast commitment to ensuring that we are strongest when a diverse and heterogeneous range of perspectives is part of our understanding of this disease at every step in the process.”
Looking ahead
Brad closed his interview by expressing his gratitude and sense of responsibility as he takes on the presidency.
“To have the opportunity to help lead with vision in this regard is extremely important and serious, and I’m excited to be here.”
As PVRI enters this new chapter, we look forward to working together — across disciplines, across regions, and across generations — to advance PH research, improve care, and strengthen our global community.